Table 2 Baseline demographics and clinical date between the stroke and control group.
From: Serum neurofilament heavy chain predicts post-stroke cognitive impairment
All (n = 58) | PSC l (n = 31) | N-PSCl (n = 27) | F/Z/χ2 | p | |
|---|---|---|---|---|---|
Age | 58.83 ± 8.91 | 63.13 ± 7.53 | 53.89 ± 7.84 | − 4.57 | < 0.01 |
Male | 42 (75.9%) | 22 (71.0%) | 20 (74.1%) | 0.07 | 0.792 |
Level of education | 9.24 ± 3.04 | 7.9 ± 2.3 | 10.7 ± 3.2 | − 2.89 | < 0.01 |
Diabetes | 17 (29.3%) | 9 (29.0%) | 8 (29.6%) | 0.002 | 0.96 |
Hypertension | 28 (48.3) | 18 (58.1%) | 10 (37.0%) | 2.55 | 0.11 |
Hyperlipemia | 40 (69.0%) | 21 (67.7%) | 19 (70.4%) | 0.04 | 0.829 |
Coronary heart disease | 1 (1.7%) | 1 (3.2%) | 0 (0.0%) | 0.88 | 0.346 |
p-NfH | 160.7(128.12,251.28) | 240.74 (157.52, 390.16) | 130.85 (116.24, 152.61) | − 4.96 | < 0.01 |
NlHSS | 2.62 ± 2.35 | 2.23 ± 2.72 | 1.93 ± 1.64 | − 1.55 | 0.03 |
Infarct volume | 1.23(0.52, 2.50) | 1.78 (0.93, 4.86) | 0.84 (0.83, 1.75) | − 2.72 | 0.007 |
TOAST somatotype | |||||
LAA | 15 (25.9%) | 9 (29.0%) | 6 (22.2%) | 0.35 | 0.555 |
Small-artery occlusion | 43 (74.1%) | 22 (71.0%) | 21 (77.8%) | ||
Lacunar infarction | 38(65.5%) | 23(74.2%) | 15(55.5%) | 5.34 | 0.021 |
Fazekas grading | |||||
Levels 0 and 1 | 35 | 13 | 22 | 9.43 | < 0.01 |
Levels 2 and 3 | 23 | 18 | 5 | ||
BMI | 26.01 ± 3.51 | 25.83 ± 3.44 | 26.22 ± 3.64 | 0.42 | 0675 |
Drinking | 26 (44.8%) | 12 (38.7%) | 14 (51.9%) | 1.01 | 0.315 |
